News

The company expects to enroll around 110 healthy subjects. The study expects to evaluate whether Matrix M is safe and improves the effect on elderly people, due to

CEN-209 is selectively activated in areas of low oxygen often found within solid tumors. Auckland Cancer Society Research Centre (ACSRC) professor William Wilson and associate professor Michael Hay,

The lawsuit was filed in connection with Glenmark‘s submission of an abbreviated new drug application (ANDA) for 0.1% hydrocortisone butyrate cream, Glenmark’s generic version of Locoid Lipocream. As

In the study, the patients will be randomized to either certolizumab pegol plus methotrexate (MTX) or adalimumab plus MTX for 12 weeks. Following this, the patients who will

ACZ885 is an investigational fully human monoclonal antibody that inhibits interleukin-1 beta (IL-1 beta), which is part of the body’s immune system defenses. ACZ885 works by neutralizing IL-1

According to the agreement, Elan will become an approximate 24% shareholder in Proteostasis. Elan will be eligible for licensing compounds that will be developed under the pact. As

Piperacillin and tazobactam for injection, the generic version of Zosyn, is indicated to treat patients with moderate to severe bacterial infections. Piperacillin is a penicillin antibiotic that fights

Under the agreement, the companies will jointly work for providing drug discovery platform to their existing and new clients to identify and develop new therapeutics targeting CNS disorder.

BAL30072, a novel siderophore (iron-binding) sulfactam antibiotic, was developed for the patients who were suffering from infections caused by multidrug-resistant Gram-negative bacteria. The Phase I study assessed the